XML 39 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 18 - Income Taxes
12 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
18.
INCOME TAXES
 
The components of income tax expense (benefit) were as follows:
 
   
Year Ended March 31,
 
   
2018
   
2017
 
Current:
               
Federal
  $
(133,000
)   $
1,124,000
 
State
   
183,000
     
128,000
 
Foreign
   
156,000
     
132,000
 
Total current
   
206,000
     
1,384,000
 
Deferred:
               
Federal
   
(14,000
)    
(592,000
)
State
   
3,000
     
(67,000
)
Total deferred
   
(11,000
)    
(659,000
)
                 
Total
  $
195,000
    $
725,000
 
 
Income tax expense was different from the amount computed by applying the statutory federal income tax rate of
30.8%
and
34%
for fiscal years ended
March 31, 2018
and
March 31, 2017
each respectively as shown in the following table:
 
   
Year Ended March 31,
 
   
2018
   
2017
 
Expected Federal income tax expense U.S. statutory rate
  $
818,000
     
30.8
%   $
(1,434,000
)    
34.0
%
State income taxes, net of Federal benefit
   
129,000
     
4.9
%    
40,000
     
-0.9
%
Permanent differences, other
   
21,000
     
0.8
%    
156,000
     
-3.7
%
Dividend received deduction
   
-
     
0.0
%    
(302,000
)    
7.2
%
Section 831(b) benefit
   
(320,000
)    
-12.1
%    
(281,000
)    
6.7
%
Change in valuation allowance
   
(1,116,000
)    
-42.1
%    
3,868,000
     
-91.8
%
Domestic production activities deductions
   
(15,000
)    
-0.6
%    
(64,000
)    
1.5
%
Income attributable to minority interest - Contrail Aviation
   
(79,000
)    
-3.0
%    
(45,000
)    
1.1
%
Bargain purchase gain
   
(155,000
)    
-5.8
%    
-
     
0.0
%
Tax rate change applied to deferreds
   
2,297,000
     
86.6
%    
-
     
0.0
%
Deferred benefit for outside basis difference recorded on Delphax CFC's
   
(811,000
)    
-30.6
%    
(1,015,000
)    
24.1
%
Deferred benefit for increase in Canadian tax credits for Dephax
   
(149,000
)    
-5.6
%    
 
     
 
 
Recognition of AMT credit as tax receivable
   
(311,000
)    
-11.7
%    
-
     
0.0
%
Deferred state income taxes, net of Federal benefit for Delphax
   
-
     
0.0
%    
(102,000
)    
2.4
%
Other differences, net
   
(114,000
)    
-4.3
%    
(96,000
)    
2.3
%
                                 
Income tax expense
  $
195,000
     
7.3
%   $
725,000
     
-17.1
%
 
Delphax, which generated a loss for the period ended
March 31, 2018
and
March 31, 2017
is
not
included in Air T, Inc.’s consolidated tax return and accounts for
$973,000
and
$3,212,000
of the above valuation allowance effect for each year, respectively. Changes in unrealized losses related to available-for-sale securities accounted for the remaining valuation allowance effect for each year. Deferred tax assets and liabilities consisted of the following as of
March 31:
 
   
2018
   
2017
 
                 
Inventory reserves
  $
50,000
    $
785,000
 
Accrued vacation
   
343,000
     
475,000
 
Stock option compensation
   
67,000
     
108,000
 
Property and equipment
   
264,000
     
169,000
 
Warranty reserve
   
25,000
     
39,000
 
Accounts and notes receivable reserve
   
103,000
     
290,000
 
Employee severance reserve
   
549,000
     
460,000
 
Net operating loss carryforwards
   
6,083,000
     
6,461,000
 
Federal/Canadian tax credits
   
4,486,000
     
4,648,000
 
263A inventory capitalization
   
-
     
10,000
 
Unrealized gains/losses and outside basis difference for CFC's
   
2,324,000
     
1,995,000
 
Intangibles
   
25,000
     
43,000
 
Outside basis difference
   
 
     
-
 
Other
   
69,000
     
78,000
 
Total deferred tax assets
   
14,388,000
     
15,561,000
 
                 
Deferred revenue
   
(11,000
)    
(35,000
)
Prepaid expenses
   
(337,000
)    
(505,000
)
263A inventory capitalization
   
(28,000
)    
-
 
Bargain purchase gain
   
(179,000
)    
-
 
Gain on marketable securities (OCI)
   
(72,000
)    
(94,000
)
Outside basis difference
   
(270,000
)    
(34,000
)
Total deferred tax liabilities
   
(897,000
)    
(668,000
)
                 
Net deferred tax asset (liability)
  $
13,491,000
    $
14,893,000
 
                 
Less valuation allowance
   
(13,583,000
)    
(14,698,000
)
                 
Net deferred tax asset (liability)
  $
(92,000
)   $
195,000
 
 
The Company accounts for uncertain tax positions in accordance with accounting principles generally accepted in the United States of America. The Company has analyzed filing positions in all of the federal, state and international jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The years subject to examination for the Company’s federal return are the fiscal
2014
through
2016
tax years. The years subject to examination for the Company’s state returns are generally the fiscal
2013
through
2016
tax years. As of
March 31, 2018
and
2017,
the Company did
not
have any unrecognized tax benefits. The Company does
not
believe there will be any material changes in unrecognized tax positions over the next
twelve
months.
 
It is the Company’s policy to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of
March 31, 2018
and
2017,
the Company did
not
have any accrued interest or penalties associated with any unrecognized tax benefits, nor was any interest expense recognized during the years ended
March 31, 2018
and
2017.
 
As described in Note
10,
effective on
November 24, 2015,
Air T, Inc. purchased interests in Delphax. With an equity investment level by the Company of approximately
38%,
Delphax is required to continue filing a separate United States corporate tax return. Furthermore, Delphax has
three
foreign subsidiaries located in Canada, France, and the United Kingdom which file tax returns in those jurisdictions. With few exceptions, Delphax is
no
longer subject to examinations by income tax authorities for tax years before
2013.
 
Delphax maintains a
September 30
fiscal year. As of
September 30, 2016,
Delphax and its subsidiaries had estimated foreign and domestic tax loss carryforwards of
$9.7
million and
$14.5
million, respectively. As of that date, they had estimated foreign research and development credit carryforwards of
$4.5
million, which are available to offset future income tax. The credits and net operating losses expire in varying amounts beginning in the year
2023.
As previously noted, the TCJA repealed the corporate alternative minimum tax and made any minimum tax credit carryforwards to the extent
not
utilized refundable for tax years beginning after
December 31, 2017.
As a result, Delphax will be able to receive a refund of its minimum tax credit carryforward of
$311,000
beginning in their fiscal year ended
September 30, 2019.
Previously, a valuation allowance was established against the minimum tax credit carryforward. As a result of the TCJA relating to the refundability of the minimum tax credit carryforward, an income tax benefit was recognized by the Company during the current period and a long-term income tax receivable was established. Should there be an ownership change for purposes of Section
382
or any equivalent foreign tax rules, the utilization of the previously mentioned carryforwards
may
be significantly limited. Furthermore, Delphax is currently undergoing bankruptcy proceedings with their Canadian entity (see Note
10
) and intends to liquidate both the United Kingdom and French entities too. The Company anticipates those proceedings will be completed within the next fiscal year. Upon completion, any remaining tax attributes, including net operating losses and credit carryforwards in each respective jurisdiction will be lost. The Company has recorded an outside basis difference in the stock of these entities of
$2.3
million which is the estimated loss that will be recognized in the United States upon their liquidation. See additional information regarding Delphax Canada in Note
10.
The returns for the fiscal year ended
September 30, 2017
have
not
yet been filed.
 
The provisions of ASC
740
require an assessment of both positive and negative evidence when determining whether it is more likely than
not
that deferred tax assets will be recovered. In accounting for the Delphax tax attributes, the Company has established a full valuation allowance of
$13.0
million at
March 31, 2018
and
$14.0
million at
March 31, 2017.
The cumulative losses incurred by Delphax in recent years was the primary basis for the Company’s determination that a full valuation allowance should be established against Delphax’s net deferred tax assets.